BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 10850453)

  • 1. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
    Park BJ; Park JI; Byun DS; Park JH; Chi SG
    Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J; Mulder KM
    J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
    Saha D; Datta PK; Beauchamp RD
    J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
    Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
    Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
    J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
    Iglesias M; Frontelo P; Gamallo C; Quintanilla M
    Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Chen RH; Su YH; Chuang RL; Chang TY
    Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
    Watanabe H; de Caestecker MP; Yamada Y
    J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
    Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
    Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
    J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.
    Kfir S; Ehrlich M; Goldshmid A; Liu X; Kloog Y; Henis YI
    Mol Cell Biol; 2005 Sep; 25(18):8239-50. PubMed ID: 16135812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate roles for H-Ras and Rac in signaling by transforming growth factor (TGF)-beta. H-Ras is essential for activation of MAP kinase, partially required for transcriptional activation by TGF-beta, but not required for signaling of growth suppression by TGF-beta.
    Yamamoto H; Atsuchi N; Tanaka H; Ogawa W; Abe M; Takeshita A; Ueno H
    Eur J Biochem; 1999 Aug; 264(1):110-9. PubMed ID: 10447679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.